BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30970517)

  • 1. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
    Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
    Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
    Wang A; Jin C; Li H; Qin Q; Li L
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.
    Xie S; Yu X; Li Y; Ma H; Fan S; Chen W; Pan G; Wang W; Zhang H; Li J; Lin Z
    Mol Ther; 2018 Dec; 26(12):2766-2778. PubMed ID: 30217729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
    Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
    Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
    Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA FALEC inhibits proliferation and metastasis of tongue squamous cell carcinoma by epigenetically silencing ECM1 through EZH2.
    Jia B; Xie T; Qiu X; Sun X; Chen J; Huang Z; Zheng X; Wang Z; Zhao J
    Aging (Albany NY); 2019 Jul; 11(14):4990-5007. PubMed ID: 31335317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt7a predicts poor prognosis, and contributes to growth and metastasis in tongue squamous cell carcinoma.
    Jia B; Qiu X; Chu H; Sun X; Xu S; Zhao X; Zhao J
    Oncol Rep; 2019 Mar; 41(3):1749-1758. PubMed ID: 30747225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
    Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
    IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.
    Ding J; Yang C; Yang S
    J Oral Pathol Med; 2018 May; 47(5):468-476. PubMed ID: 29315846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
    Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
    Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNHG1/miR-194-5p/MTFR1 Axis Promotes TGFβ1-Induced EMT, Migration and Invasion of Tongue Squamous Cell Carcinoma Cells.
    Jia Y; Chen X; Zhao D; Ma S
    Mol Biotechnol; 2022 Jul; 64(7):780-790. PubMed ID: 35107755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
    Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
    Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
    Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y
    Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation.
    He S; Wang X; Zhang J; Zhou F; Li L; Han X
    Cell Cycle; 2020 Aug; 19(15):1969-1982. PubMed ID: 32615889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling.
    Yang ZH; Li J; Chen WZ; Kong FS
    Cell Biochem Funct; 2020 Oct; 38(7):943-954. PubMed ID: 32325539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
    Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
    J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-611 promotes the proliferation, migration and invasion of tongue squamous cell carcinoma cells by targeting FOXN3.
    Chen S; Zhang J; Sun L; Li X; Bai J; Zhang H; Li T
    Oral Dis; 2019 Nov; 25(8):1906-1918. PubMed ID: 31419344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma.
    Yu J; Liu Y; Gong Z; Zhang S; Guo C; Li X; Tang Y; Yang L; He Y; Wei F; Wang Y; Liao Q; Zhang W; Li X; Li Y; Li G; Xiong W; Zeng Z
    Oncotarget; 2017 Mar; 8(10):16621-16632. PubMed ID: 28039470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.